- Home
- VIVS vs AMZE Comparison
VIVS vs AMZE Comparison
Compare VIVS & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VIVS | AMZE |
|---|---|---|
| Founded | 2007 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 8.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | VIVS | AMZE |
|---|---|---|
| Price | $1.98 | $0.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 41.6K | ★ 33.5M |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $140,000.00 | ★ $2,245,143.00 |
| Revenue This Year | $42.38 | $6,741.66 |
| Revenue Next Year | $15.42 | $100.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 35.92 | ★ 369.95 |
| 52 Week Low | $1.41 | $0.24 |
| 52 Week High | $21.96 | $19.44 |
Technical Indicators
Market Signals| Indicator | VIVS | AMZE |
|---|---|---|
| Relative Strength Index (RSI) | 36.62 | 33.78 |
| Support Level | $2.11 | $0.34 |
| Resistance Level | $2.51 | $0.45 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 10.97 | 23.54 |
Price Performance
Historical ComparisonAbout VIVS VivoSim Labs Inc.
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About AMZE Amaze Holdings Inc.
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.